• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 29, 2022

    3/29/22 5:03:02 AM ET
    $AMPE
    $AREC
    $ASO
    $BCDA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Coal Mining
    Energy
    Get the next $AMPE alert in real time by email

     

    Companies Reporting Before The Bell

    • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

    • Imperial Ptrl (NASDAQ:IMPP) is estimated to report earnings for its fourth quarter.

    • Lovesac (NASDAQ:LOVE) is expected to report quarterly earnings at $0.54 per share on revenue of $174.33 million.

    • Comstock Mining (AMEX:LODE) is expected to report earnings for its fourth quarter.

    • EHang Holdings (NASDAQ:EH) is expected to report earnings for its fourth quarter.

    • Conn's (NASDAQ:CONN) is projected to report quarterly earnings at $0.48 per share on revenue of $412.22 million.

    • SCYNEXIS (NASDAQ:SCYX) is estimated to report quarterly loss at $0.77 per share on revenue of $1.16 million.

    • Academy Sports (NASDAQ:ASO) is expected to report quarterly earnings at $1.42 per share on revenue of $1.77 billion.

    • Humacyte (NASDAQ:HUMA) is projected to report earnings for its fourth quarter.

    • Wejo Gr (NASDAQ:WEJO) is likely to report quarterly loss at $0.21 per share on revenue of $2.05 million.

    • Kala Pharmaceuticals (NASDAQ:KALA) is expected to report quarterly loss at $0.41 per share on revenue of $3.41 million.

    • Jupai Hldgs (NYSE:JP) is expected to report earnings for its fourth quarter.

    • SPAR Group (NASDAQ:SGRP) is expected to report earnings for its fourth quarter.

    • Elbit Systems (NASDAQ:ESLT) is expected to report quarterly earnings at $1.89 per share on revenue of $1.26 billion.

    • Uxin (NASDAQ:UXIN) is projected to report earnings for its third quarter.

    • I-MAB (NASDAQ:IMAB) is projected to report earnings for its Fiscal Year 2021.

    • Berkshire Grey (NASDAQ:BGRY) is likely to report quarterly loss at $0.13 per share on revenue of $22.01 million.

    • Safe-T Gr (NASDAQ:SFET) is projected to report quarterly loss at $0.08 per share on revenue of $3.55 million.

    • Better Choice Co (AMEX:BTTR) is projected to report quarterly loss at $0.12 per share on revenue of $11.01 million.

    • Solo Brands (NYSE:DTC) is projected to report quarterly earnings at $0.32 per share on revenue of $174.37 million.

    • Genetron Holdings (NASDAQ:GTH) is expected to report earnings for its fourth quarter.

    • BIO-key Intl (NASDAQ:BKYI) is estimated to report quarterly loss at $0.15 per share on revenue of $1.40 million.

    • McCormick & Co (NYSE:MKC) is estimated to report quarterly earnings at $0.62 per share on revenue of $1.47 billion.

    • P & F Industries (NASDAQ:PFIN) is likely to report earnings for its fourth quarter.

    • Burford Capital (NYSE:BUR) is projected to report earnings for its Fiscal Year 2021.

     

    Companies Reporting After The Bell

    • Valhi (NYSE:VHI) is estimated to report quarterly earnings at $0.01 per share on revenue of $6.87 million.

    • SenesTech (NASDAQ:SNES) is expected to report quarterly loss at $0.21 per share on revenue of $290.00 thousand.

    • TOMI Environmental Solns (NASDAQ:TOMZ) is expected to report quarterly loss at $0.02 per share on revenue of $2.73 million.

    • Core Scientific (NASDAQ:CORZ) is likely to report quarterly earnings at $0.33 per share on revenue of $186.07 million.

    • Ampio Pharmaceuticals (AMEX:AMPE) is expected to report earnings for its fourth quarter.

    • Rani Therapeutics Hldgs (NASDAQ:RANI) is projected to report quarterly loss at $0.49 per share on revenue of $160.00 thousand.

    • VIQ Solutions (NASDAQ:VQS) is likely to report quarterly loss at $0.07 per share on revenue of $12.26 million.

    • Sundial Growers (NASDAQ:SNDL) is likely to report earnings for its fourth quarter.

    • RH (NYSE:RH) is projected to report quarterly earnings at $5.58 per share on revenue of $931.78 million.

    • Synalloy (NASDAQ:SYNL) is estimated to report earnings for its fourth quarter.

    • Draganfly (NASDAQ:DPRO) is projected to report earnings for its fourth quarter.

    • Motus GI Hldgs (NASDAQ:MOTS) is expected to report quarterly loss at $0.10 per share on revenue of $140.00 thousand.

    • Urban-gro (NASDAQ:UGRO) is expected to report quarterly loss at $0.04 per share on revenue of $18.83 million.

    • Stronghold Digital Mining (NASDAQ:SDIG) is projected to report quarterly earnings at $0.04 per share on revenue of $20.68 million.

    • Infinity Pharmaceuticals (NASDAQ:INFI) is estimated to report quarterly loss at $0.13 per share on revenue of $300.00 thousand.

    • BioCardia (NASDAQ:BCDA) is estimated to report quarterly loss at $0.21 per share on revenue of $40.00 thousand.

    • Cormedix (NASDAQ:CRMD) is likely to report quarterly loss at $0.23 per share on revenue of $20.00 thousand.

    • NovaBay Pharmaceuticals (AMEX:NBY) is projected to report quarterly loss at $0.05 per share on revenue of $3.34 million.

    • HTG Molecular Diagnostics (NASDAQ:HTGM) is estimated to report quarterly loss at $0.59 per share on revenue of $2.97 million.

    • Oblong (NASDAQ:OBLG) is projected to report earnings for its fourth quarter.

    • American Res (NASDAQ:AREC) is projected to report earnings for its fourth quarter.

    • Cal-Maine Foods (NASDAQ:CALM) is estimated to report quarterly earnings at $0.83 per share on revenue of $468.84 million.

    • CEA Industries (NASDAQ:CEAD) is estimated to report earnings for its fourth quarter.

    • Sunlight Financial (NYSE:SUNL) is estimated to report quarterly loss at $0.02 per share on revenue of $33.21 million.

    • Concentrix (NASDAQ:CNXC) is expected to report quarterly earnings at $2.71 per share on revenue of $1.53 billion.

    • PVH (NYSE:PVH) is likely to report quarterly earnings at $2.00 per share on revenue of $2.38 billion.

    • Winc (AMEX:WBEV) is projected to report quarterly loss at $0.90 per share on revenue of $17.03 million.

    • Chewy (NYSE:CHWY) is likely to report quarterly loss at $0.08 per share on revenue of $2.42 billion.

    • Tricida (NASDAQ:TCDA) is expected to report earnings for its fourth quarter.

    • Dyadic International (NASDAQ:DYAI) is likely to report quarterly loss at $0.02 per share on revenue of $3.78 million.

    • Sera Prognostics (NASDAQ:SERA) is likely to report quarterly loss at $0.29 per share on revenue of $130.00 thousand.

    • Nabriva Therapeutics (NASDAQ:NBRV) is expected to report quarterly loss at $0.19 per share on revenue of $10.10 million.

    • CohBar (NASDAQ:CWBR) is likely to report earnings for its fourth quarter.

    • Sarcos Technology (NASDAQ:STRC) is likely to report quarterly loss at $0.07 per share on revenue of $1.35 million.

    • Kore Group Holdings (NYSE:KORE) is likely to report quarterly loss at $0.11 per share on revenue of $58.22 million.

    • OpGen (NASDAQ:OPGN) is likely to report quarterly loss at $0.15 per share on revenue of $1.40 million.

    • PAVmed (NASDAQ:PAVM) is expected to report quarterly loss at $0.15 per share on revenue of $520.00 thousand.

    • Cue Health (NASDAQ:HLTH) is expected to report quarterly earnings at $0.10 per share on revenue of $185.29 million.

    • SomaLogic (NASDAQ:SLGC) is likely to report quarterly loss at $0.13 per share on revenue of $20.47 million.

    • Microvast Holdings (NASDAQ:MVST) is projected to report quarterly loss at $0.07 per share on revenue of $60.00 million.

    • Sportsman's Warehouse (NASDAQ:SPWH) is estimated to report quarterly earnings at $0.46 per share on revenue of $407.01 million.

    • MillerKnoll (NASDAQ:MLKN) is projected to report quarterly earnings at $0.27 per share on revenue of $1.03 billion.

    • Verint Systems (NASDAQ:VRNT) is estimated to report quarterly earnings at $0.56 per share on revenue of $231.60 million.

    • Progress Software (NASDAQ:PRGS) is estimated to report quarterly earnings at $0.85 per share on revenue of $140.55 million.

    • Zovio (NASDAQ:ZVO) is estimated to report quarterly loss at $0.11 per share on revenue of $56.50 million.

    • Lululemon Athletica (NASDAQ:LULU) is projected to report quarterly earnings at $3.28 per share on revenue of $2.13 billion.

    • Micron Technology (NASDAQ:MU) is likely to report quarterly earnings at $1.97 per share on revenue of $7.52 billion.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AMPE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMPE
    $AREC
    $ASO
    $BCDA

    CompanyDatePrice TargetRatingAnalyst
    Rani Therapeutics Holdings Inc.
    $RANI
    4/14/2026$9.00Buy
    Lake Street
    McCormick & Company Incorporated
    $MKC
    4/14/2026Neutral
    BTIG Research
    Micron Technology Inc.
    $MU
    4/3/2026Buy → Hold
    Erste Group
    Micron Technology Inc.
    $MU
    4/2/2026Buy → Hold
    Erste Group
    Burford Capital Limited
    $BUR
    3/30/2026$4.75Outperform → Neutral
    Wedbush
    Draganfly Inc.
    $DPRO
    3/25/2026$14.00 → $12.00Buy
    Needham
    RH
    $RH
    3/25/2026$185.00 → $165.00Market Perform
    Telsey Advisory Group
    PVH Corp.
    $PVH
    3/24/2026$82.00 → $74.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $AMPE
    $AREC
    $ASO
    $BCDA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Human Relations Officer Piper Sarah

    4 - MCCORMICK & CO INC (0000063754) (Issuer)

    4/23/26 3:37:17 PM ET
    $MKC
    Packaged Foods
    Consumer Staples

    SEC Form 4 filed by Chairman, President & CEO Foley Brendan M

    4 - MCCORMICK & CO INC (0000063754) (Issuer)

    4/23/26 3:35:52 PM ET
    $MKC
    Packaged Foods
    Consumer Staples

    Director Lim Boh Soon was granted 10,000 shares, increasing direct ownership by 5% to 208,524 units (SEC Form 4)

    4 - TOMI Environmental Solutions, Inc. (0000314227) (Issuer)

    4/23/26 3:27:35 PM ET
    $TOMZ
    Major Chemicals
    Industrials

    $AMPE
    $AREC
    $ASO
    $BCDA
    SEC Filings

    View All

    Humacyte Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Humacyte, Inc. (0001818382) (Filer)

    4/24/26 8:09:43 AM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by Core Scientific Inc.

    SCHEDULE 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

    4/23/26 8:59:17 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    SEC Form DEFA14A filed by Palladyne AI Corp.

    DEFA14A - Strategy Inc (0001050446) (Filer)

    4/23/26 4:29:42 PM ET
    $STRC
    Wholesale Distributors
    Industrials

    $AMPE
    $AREC
    $ASO
    $BCDA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 17, 2023 - FDA Roundup: November 17, 2023

    For Immediate Release: November 17, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, to mark the 15th anniversary of the FDA foreign offices, the FDA published an interview with Susan Winckler, who was FDA chief of staff when the first office was opened in Beijing on November 19, 2008. Winckler is now CEO of the Reagan-Udall Foundation

    11/17/23 4:18:44 PM ET
    $BMY
    $CRMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DEFENCATH issued to CORMEDIX INC

    Submission status for CORMEDIX INC's drug DEFENCATH (ORIG-1) with active ingredient TAUROLIDINE AND HEPARIN SODIUM has changed to 'Approval' on 11/15/2023. Application Category: NDA, Application Number: 214520, Application Classification: Type 1 - New Molecular Entity and Type 4 - New Combination

    11/15/23 9:53:06 AM ET
    $CRMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMPE
    $AREC
    $ASO
    $BCDA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

    NEW YORK, April 24, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced the closing of its previously announced underwritten registered direct offering of 18,000,000 common shares at a purchase price of $1.00 per share, anchored by a $15 million investment from a fundamental institutional investor with support from a large existing shareholder. The gross proceeds from the offering, before deducting underwriting discount

    4/24/26 10:23:00 AM ET
    $LUCD
    $PAVM
    Medical/Dental Instruments
    Health Care

    Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®

    - Ex-U.S. rights realigned under amendment to distribution agreement with Fresenius Medical Care -  - Positions Humacyte to advance discussions with corporate partners regarding international and indication-specific rights to Symvess – - Existing terms related to U.S. distribution of Symvess remain unchanged DURHAM, N.C., April 24, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has realigned the ex-U.S. rights to Symvess (acellular tissue engineered vessel) through an amendment to its distribution agreement with Fresenius

    4/24/26 8:00:00 AM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    36Kr Holdings Inc. Files 2025 Annual Report on Form 20-F

    BEIJING, April 23, 2026 (GLOBE NEWSWIRE) -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ:KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission (the "SEC") on April 23, 2026. The annual report can be accessed on the Company's investor relations website at http://ir.36kr.com and on the SEC's website at www.sec.gov. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon

    4/23/26 9:25:48 AM ET
    $KRKR
    Real Estate

    $AMPE
    $AREC
    $ASO
    $BCDA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on Rani Therapeutics with a new price target

    Lake Street initiated coverage of Rani Therapeutics with a rating of Buy and set a new price target of $9.00

    4/14/26 9:27:33 AM ET
    $RANI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BTIG Research initiated coverage on McCormick

    BTIG Research initiated coverage of McCormick with a rating of Neutral

    4/14/26 8:24:09 AM ET
    $MKC
    Packaged Foods
    Consumer Staples

    Micron downgraded by Erste Group

    Erste Group downgraded Micron from Buy to Hold

    4/3/26 10:44:59 AM ET
    $MU
    Semiconductors
    Technology

    $AMPE
    $AREC
    $ASO
    $BCDA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $330,182 worth of shares (171,034 units at $1.93) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    3/17/26 8:10:19 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Director Weiss Eric Stanton bought $101,700 worth of shares (7,000 units at $14.53), increasing direct ownership by 3% to 252,262 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    3/10/26 4:08:53 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AMPE
    $AREC
    $ASO
    $BCDA
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $AMPE
    $AREC
    $ASO
    $BCDA
    Financials

    Live finance-specific insights

    View All

    SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026

    SALT LAKE CITY, April 22, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ:SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced it will report first quarter fiscal year 2026 financial results on Wednesday May 6, 2026, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. Eastern Time. A press release outlining the financial results and highlights will be publicly distributed before the call.

    4/22/26 8:05:00 AM ET
    $SERA
    Medical Specialities
    Health Care

    The Three-Layer Counter-UAS Stack: VisionWave Assembles RF + Computer Vision + AI Video Analytics Architecture with Foresight Investment

    Issued on behalf of VisionWave Holdings, Inc.VisionWave Holdings (NASDAQ:VWAV) signs a non-binding term sheet to acquire up to 51% of Foresight Autonomous Holdings (NASDAQ:FRSX), adding camera-based stereo vision and thermal perception to its existing RF sensing core and the xClibre™ AI video intelligence platform — building toward a three-layer counter-UAS architecture targeting its Argus™ platform and intended to reduce false-positive engagement rates.Companies mentioned in this article:VisionWave Holdings, Inc. (NASDAQ:VWAV), Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX), L3Harris Technologies, Inc. (NYSE:LHX), Teledyne Technologies Incorporated (NYSE:TDY), Elbit Systems Ltd. (NASDAQ:E

    4/21/26 9:59:00 AM ET
    $ESLT
    $FRSX
    $LHX
    Military/Government/Technical
    Industrials
    Computer Software: Prepackaged Software
    Technology

    SNDL to Report First Quarter 2026 Financial Results on April 29, 2026

    EDMONTON, Alberta, April 15, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL") announced today that it will release its first quarter 2026 financial results for the period ended March 31, 2026, before markets open on Wednesday, April 29, 2026. Following the release of its first quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on April 29, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/9eyekwcv  ABOUT SNDL INC. SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integrated cannabis com

    4/15/26 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    $AMPE
    $AREC
    $ASO
    $BCDA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Microvast Holdings Inc.

    SC 13D/A - Microvast Holdings, Inc. (0001760689) (Subject)

    11/21/24 9:41:30 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by Humacyte Inc.

    SC 13D/A - Humacyte, Inc. (0001818382) (Subject)

    11/20/24 7:10:08 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Humacyte Inc.

    SC 13D/A - Humacyte, Inc. (0001818382) (Subject)

    11/18/24 4:10:14 PM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMPE
    $AREC
    $ASO
    $BCDA
    Leadership Updates

    Live Leadership Updates

    View All

    urban-gro, Inc. (Nasdaq: UGRO) — Sri Lanka Cricket Confirms July 10 – August 5, 2026 and Four Venues for Lanka Premier League Season 6; Tournament Conducted in Partnership with UGRO Subsidiary IPG Group

    LAFAYETTE, Colo., April 23, 2026 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), operating through Flash Sports & Media, Inc., today noted the official announcement by Sri Lanka Cricket ("SLC") confirming the dates, venues, and player-registration timeline for Lanka Premier League ("LPL") Season 6. The tournament will run from July 10 to August 5, 2026, and is owned by SLC and conducted in partnership with Innovative Production Group FZ, LLC ("IPG"), the event rights holder. The Company participates in the tournament through its subsidiary, IPG under existing commercial arrangements. Season 6 — By the Numbers Tournament windowJuly 10 – August 5, 2026 (

    4/23/26 7:05:00 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    lululemon Names Proven Brand Builder Heidi O'Neill as Chief Executive Officer

    O'Neill is a visionary, consumer-focused executive with more than three decades of experience leading brand strategy, product innovation, and operational execution on a global scale lululemon athletica inc. (NASDAQ:LULU) today announced that, following a comprehensive search process, the company's Board of Directors has unanimously approved the appointment of industry veteran Heidi O'Neill as the company's next Chief Executive Officer. Ms. O'Neill will start as CEO and join the Board effective September 8, 2026, and will be based in Vancouver. "Heidi is an inspiring leader and proven, consumer-driven brand strategist, with a rare ability to both imagine a new future for a brand and to c

    4/22/26 4:05:00 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    Humacyte Appoints Jim Mercadante as Chief Commercial Officer

    – Industry veteran with more than 25 years of experience will lead next phase of biotech company's commercial expansion – – Seasoned medtech commercial leader brings extensive field-specific success in vascular and cardiothoracic surgery markets – – Appointment strengthens commercial leadership as Symvess® (acellular tissue engineered vessel-tyod) market launch accelerates and pipeline advances toward planned BLA filing in dialysis – DURHAM, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the appointment of Jim Merc

    4/22/26 8:00:00 AM ET
    $HUMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care